NCT02910895View on ClinicalTrials.gov

A Platform of Patient Derived Xenografts (PDX) and 2D/3D Cell Cultures of Soft Tissue Sarcomas (STS)

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 9, 2017

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions
Soft Tissue SarcomaXenograft Model2D/3D Cell Cultures
Interventions
OTHER

tumor biopsy

biopsy

Trial Locations (1)

1066CX

RECRUITING

Netherlands Cancer Institute, Amsterdam

All Listed Sponsors
collaborator

KU Leuven

OTHER

lead

The Netherlands Cancer Institute

OTHER